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Abstract
Integrative network modeling of data arising from multiple genomic platforms pro-
vides insight into the holistic picture of the interactive system, as well as the flow of
information across many disease domains including cancer. The basic data structure
consists of a sequence of hierarchically ordered datasets for each individual subject,
which facilitates integration of diverse inputs, such as genomic, transcriptomic, and
proteomic data. A primary analytical task in such contexts is to model the layered
architecture of networks where the vertices can be naturally partitioned into ordered
layers, dictated by multiple platforms, and exhibit both undirected and directed
relationships. We propose a multi-layered Gaussian graphical model (mlGGM) to
investigate conditional independence structures in such multi-level genomic networks
in human cancers. We implement a Bayesian node-wise selection (BANS) approach
based on variable selection techniques that coherently accounts for the multiple types
of dependencies in mlGGM; this flexible strategy exploits edge-specific prior knowl-
edge and selects sparse and interpretable models. Through simulated data generated
under various scenarios, we demonstrate that BANS outperforms other existing mul-
tivariate regression-based methodologies. Our integrative genomic network analysis
for key signaling pathways across multiple cancer types highlights commonalities and
differences of p53 integrative networks and epigenetic effects of BRCA2 on p53 and
its interaction with T68 phosphorylated CHK2, that may have translational utilities
of finding biomarkers and therapeutic targets.
Keywords: Multi-level data integration, Multi-layered Gaussian graphical models, Bayesian
variable selection
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1 Introduction
Cancer is a complex disease that is caused by deregulation of several molecular processes
and cellular pathways, usually triggered by genetic alterations in specific sets of genes
(Hanahan and Weinberg, 2000, 2011; Creixell et al., 2012, 2015). Pathway and net-
work analysis aim to gain insight into these underlying interactive mechanisms, and to
reduce data involving thousands of altered genes and proteins to a smaller, and more
interpretable set of functionally altered processes (Pe’er and Hacohen, 2011). The Can-
cer Genome Atlas (TCGA) has generated a rich source of multi-dimensional genomics
(’omics for short) data for patients across multiple tumor types and their subtypes (http:
//cancergenome.nih.gov). More recently, The Cancer Proteome Atlas (TCPA) (http:
//bioinformatics.mdanderson.org/main/TCPA:Overview) has generated a complemen-
tary set of reverse phase protein array (RPPA)-based proteomic data across most of these
patients’ samples, covering major oncogenic signaling pathways (Li et al., 2013; Akbani
et al., 2014). Multi-level integration and processing of network information across these
modalities is emerging, based on the principle that any biological mechanism is a systematic
conflation of multiple molecular events and their interactions (Kristensen et al., 2014).
The basic data structure constitutes of a finite sequence of hierarchically-ordered datasets
for each individual subject, which facilitates integration of diverse inputs such as genomic,
transcriptomic, and proteomic data to investigate the unified regulatory mechanisms under-
lying the biology of various cancers. Figure 1 shows a conceptual data structure that allows
for the characterization of dependencies within and between the datasets from the ordered
layers. Two types of edges characterize the network structure: undirected edges within
each layer, and directed edges to distinguish variables in a layer from variables in all the
previous layers. Most integrative analyses rely on directed relationships between different
data platforms based on the biological mechanisms (Wang et al., 2013), and the variables
observed from each platform constitute a layer. For example, following the central dogma
of biology, the first layer could constitute DNA-level data (copy number, methylation), the
second layer the transcriptomic (mRNA expression), and the third layer proteomic data. In
this context, the directed edges capture cross-platform (e.g., transcriptional, translational)
dependencies, and the undirected edges capture the within-platform dependencies.
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Figure 1: Example network for q ordered layers.In our application, we consider four layers
corresponding to DNA methylation, Copy number aberration, gene expression and protein
expression (see Section 7).
Modeling each of the layers independently does not account for the hierarchical multi-
layered structure of the data, and can only provide information on how networks operate
at a static point in time or under a static condition. A critical next step is to understand
a holistic and dynamic picture of the interactive system and the information flow, which
can only be achieved by simultaneously modeling multiple layers of data. Our objective
is to investigate the conditional dependencies among the variables from multiple layers,
while accounting for the order defined by the underlying layered structure of the data.
Statistically, this translates to a structural estimation of graphs with a mixture of directed
and undirected edges. This objective poses significant methodological and computational
challenges, however, to building a single graphical model that includes hierarchical multiple
graphs with directed edges for dependencies, constrained by orders between layers, as well
as with undirected edges for unconstrained dependencies within layers.
Chain graphs have been used to model the layered architecture of networks, where
the vertices can be naturally partitioned into ordered sets that exhibit undirected and
directed acyclic relations within and between the sets. The conditional independencies that
correspond to missing edges (i.e., Markov properties in the chain graphs) have been studied
by Lauritzen and Wermuth (1989); Frydenberg (1990); Andersson et al. (2001). Drton and
Eichler (2006) introduced a point-estimation approach to maximum likelihood estimation
given the graph structure, and Drton and Perlman (2008) proposed a constraint-based
method to estimate the structure. However, all of the above-mentioned methods for chain
graphs are restricted to low-dimensional data with sample sizes larger than the number of
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vertices.
In its simplest form (two layers), a chain graph is equivalent to a multiple multivariate
regression model. Multiple predictors affect multiple responses that exhibit a correlation
structure, and both regression coefficients (for directed edges) and the error precision ma-
trix (for undirected edges) are assumed to be typically sparse. Approaches based on the
doubly-penalized joint likelihood have been proposed by Rothman et al. (2010); Yin and
Li (2011). A joint L1 penalty was imposed on both the regression coefficients and the pre-
cision matrix, resulting in a penalized likelihood that is bi-convex (but not convex), which
implies that the optimization algorithm may be unstable and fail to converge (Lee and Liu,
2012). Cai et al. (2012); Chen et al. (2016) proposed a two-step approach, in which only
regression coefficients are estimated in the first step, and then the error inverse covariance
matrix is obtained in the second step, given the estimated regression parameters. To select
good initial parameters for this bi-convex problem, Lin et al. (2016) proposed an L1 pe-
nalized maximum likelihood estimation with prescreening of variables, and extended this
methodology to multi-layered graphs with an arbitrary number of layers. In a Bayesian
framework, Bhadra and Mallick (2013); Consonni et al. (2017) proposed a Bayesian model
based on the hyper-inverse Wishart prior on the covariance matrix, which assumes that
the UGs within each layer are decomposable. The decomposability assumption is generally
restrictive, explores a smaller model space, and potentially provides misspecification of the
structure for networks in many real applications.
In this article, we propose a novel approach for a multi-layered Gaussian graphical model
(mlGGM) that accommodates data from an arbitrary number of layers. The mlGGM is a
special case of the chain graph model, where the random variables that correspond to the
vertices are assumed to follow a multivariate Gaussian distribution, and the zero structures
of the mean parameter and the precision parameter directly link to the absence of the
directed and undirected edges, respectively. We construct a regression-based formulation
that converts the mlGGM into a more tractable node-wise multiple regression model. We
generalize the node-wise multiple regression approach that coherently accounts for condi-
tional independencies in mlGGMs. We jointly select both undirected and directed edges
that point to a vertex via Bayesian variable selection priors for each of the regressions,
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allowing for a much larger graph space than that of decomposable graphs. Moreover,
the prior formulation allows for the incorporation of relevant prior knowledge through the
edge-specific informative prior, and provides a computationally more efficient procedure to
estimate mlGGMs.
Through simulation studies under various settings of the mlGGMs, we demonstrate the
utility of our node-wise regression framework in the structural recovery of the mlGGM,
and compare its performance to those of related multivariate regression-based methods.
We also numerically evaluate sign consistency (i.e., whether our univariate regression-based
formulation correctly finds the signs of the undirected and directed dependencies when we
have the known structure). We illustrate the applicability and versatility of mlGGMs to
infer integrated genomic networks for multi-omic data, using biological hierarchies among
the platforms across multiple cancers. The signed topological structure obtained from our
method allows for more refined inference of both cross- and within-platform dependencies,
including the inhibition/activation between platforms and positive/negative correlations
within platforms. Furthermore, we investigate the commonalities and differences in their
multi-layered network structures across cancer types, and show translational utilities of
these integrative networks.
The rest of this article is organized as follows. Section 2 provides data structure and
backgrounds on mlGGMs. Section 3 presents the joint model and the corresponding prior
construction. We introduce our Bayesian node-wise selection (BANS) framework in Section
4. We discuss posterior inference on graphical structure estimation in Section 5. Simulation
studies are carried out in Section 6. We demonstrate the utility of our method in multi-
layered genomic network studies across cancer types in Section 7. Section 8 concludes the
article.
2 Background
2.1 Data structure
We consider a graphical model over p biological units across multi-omic data, Y = (Y1, . . . , Yp)
T ∈
Rp. Here p could constitute different platform-specific observations (e.g., genes, proteins,
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etc.), but for ease of conceptual and technical exposition, we use genes throughout. A
graph of Y can be denoted by G = (V,E), where V = {1, . . . , p} includes all genes across
platforms, and E may contain both directed (→) and undirected edges (−) between the
genes. We assume to know a priori that a partitioning T = {τk|1 ≤ k ≤ q}, q ≤ p, is a
family of pairwise disjoint ordered layers of p genes. The ordered partitioning T implies that
any edges between the layers are directed. In other words, each layer τk constitutes genes
from a platform, and the layers are ordered according to a biological hierarchy. Formally,
the partitioning T is called a dependence chain if
k < l =⇒ v 9 u ∀u ∈ τk, v ∈ τl.
In other words, when k < l, any edges between τk and τl point from a vertex in τk to a
vertex in τl. For each v ∈ V , let 1 ≤ t(v) ≤ q be the index, such that v ∈ τt(v). We assume
without loss of generality that the vertices are labeled, such that,
t(u) < t(v) =⇒ u < v.
Factorization based on biological hierarchies. The integrative genomic analyses for multi-
platform genomics data can be performed based on coherent biological justifications mo-
tivated by their hierarchical dependencies. Following the central dogma of biology, where
the epigenetic and DNA level, such as methylation and copy number variation, potentially
regulate mRNA expression (transcription regulation), which in turn is known to regulate
protein expressions (translation regulation) (Morris and Baladandayuthapani, 2017). For
our case study, we integrate four datasets from copy number aberration (CNA), methyla-
tion, mRNA expression, and protein expression, and the dependence chain (T ) constitutes
four (q) disjoint sets that have their own unique order: (CNA, methylation) < mRNA <
protein (see Figure 5)
Notationally, if u → v, the vertex u is a parent of v. Let pav = {u ∈ V : u → v ∈ E}
and paA = ∪v∈Apav \ A be the sets of parents of v and a subset A ⊆ V , respectively. We
assume the dependence chain allows for factorization of DAGs at the layer level (i.e., the
graph in Figure 1 is a DAG of the dependence chain, τ1, . . . , τq). We denote the sub-vector
of Y corresponding to a subset A ⊂ V by Y A. The joint probability distribution of Y can
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be factorized as
P (Y ) =
∏
τ∈T
P (Y τ |Y paτ ) (1)
(Lauritzen, 1996). Through factorization, the network structure in Figure 1 can be viewed
as q− 1 two-layered models, such as {Y τm : m = 1, . . . , k− 1} versus Y τk for k > 1, plus a
one-layered UG model for Y τ1 . In the example of using DNA methylation, CNA, mRNA
expression and protein expression, the multi-layered networks can be constructed from two
UG models for CNA and methylation, and two two-layered models for mRNA and protein
expressions.
To complete our chain graph model, we specify the Markov property. For a dependence
chain T , we define the cumulatives to be the set Cl = ∪k≤lτk for 1 ≤ l ≤ q. Andersson
et al. (2001) proposed a Markov property for chain graphs and set the pairwise Markov
property for G as
u− v /∈ E =⇒ Yu |= Yv|Y Ct(v)\{u,v} for t(u) = t(v)
u→ v /∈ E =⇒ Yu |= Yv|Y Ct(v)−1 \{u} for t(u) < t(v). (2)
A missing directed edge between two random variables Yu and Yv implies that they are
conditionally independent, given all other variables in τ1, . . . , τt(v)−1, while the conditional
set of missing undirected edges is all other variables in τ1, . . . , τt(v).
2.2 Multi-layered Gaussian graphical models
In this section, we specify each factor in (1). We assume that the p × 1 random vector
Y follows the multivariate Gaussian distribution N(0,Ω−1), with the positive definite
precision matrix Ω. The mlGGM G = (V,E), following the Markov property stated in (2),
is
Y = BY + ,  ∼ N(0,K−1), (3)
where B = (bvu) is a p× p matrix with u→ v /∈ E ⇔ bvu = 0, and K = (κvu) is a positive
definite p× p matrix with v − u /∈ E ⇔ κuv = κvu = 0. Then the precision matrix of Y is
Ω = (I−B)TK(I−B), (4)
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where I is an identity matrix. B is a coefficient matrix for which the zero structures encode
the directed edges between layers. The precision matrix of the error , K is a symmetric
matrix, where the nonzero off-diagonal elements represent the undirected edges within a
layer after taking out the effects from the directed edges, and the ith diagonal element is
the inverse variance of Yi.
The mlGGM in (3) for a dependence chain T with |T | = q > 1 can be expressed as one
GGM for τ1 and q−1 two-layered GGMs by the factorization in (1). For a matrix A = (aij),
we denote sub-matrices AS1,S2 = (aij)i∈S1,j∈S2 and AS = (aij)i∈S,j∈S . We also denote the
transpose of a sub-matrix, ATS1,S2 = (AS1,S2)
T. Under the factorization in equation (1), the
model in (3) can be re-expressed as the component-wise conditional distributions:
Y τ |Y paτ ∼ N(Bτ,paτY paτ ,K−1τ ) for all τ ∈ T . (5)
Because the first layer τ1 has an empty parent set, it has zero mean in (5) and is equivalent
to the UG. The conditional distribution corresponds to a multivariate multiple regression,
where the block of variables Y τ is regressed on the parents Y paτ .
There are other formulations of chain graphs based on the Lauritzen-Wermuth-Frydenberg
(LWF) Markov property (Lauritzen and Wermuth, 1989; Frydenberg, 1990). In the case of
continuous variables with a joint multivariate Gaussian distribution, the Markov property
in (2) is coherent with data generated by the linear system in (5) (Cox and Wermuth, 1993;
Andersson et al., 2001; Drton and Eichler, 2006). Further details on implication of Markov
properties are in Section S1.
3 Joint model and prior construction
In this section, we discuss the estimation problem of the multi-layered graph structure
that includes both directed and undirected edges, which induces network-based integration
of multi-omic data. Under known T , our focus is to estimate the zero-structures of B
and K that encode the directed edges and undirected edges between and within layers,
respectively. For directed edges, the problem boils down to finding the parents, pav for
v ∈ τk ⊆ V from the cumulative Ck−1 , which is the union of all the preceding layers of τk.
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The model corresponding to the first layer, τ1, is given by
Y τ1 ∼ N(0,K−1τ1 ), (6)
where there are no predictors. From the second component to the last component, τ2, . . . τq
with |T | = q, the structure of the model is expressed by the following multivariate multiple
regressions:
Y τk = Bτk,Ck−1Y Ck−1 + τk , and τk ∼ N(0,K−1τk ), k = 2, ..., q, (7)
where Ck is the cumulative for the kth layer. The model for the first layer only involves the
parameter for the precision matrix Kτ1 , which is a traditional model for UGs (Lauritzen,
1996). The parameters of interest are the coefficient matrices {Bτk,Ck−1 : k = 2, . . . , q},
which encode the directed edges across the layers, and {Kτk : k = 1, . . . , q}, which encode
the conditional dependencies within the layers, after adjusting for the effects from the
directed edges. Fitting the set of regression models can be performed independently and in
parallel, assuming priors over the parameters that are independent across the regressions.
Component-wise regressions. In this component-wise regression framework, we can use the
Inverse Wishart prior for K−1τk and the independent normal priors for elements of Bτk,Ck−1 :
for all k = 1, . . . , q,
K−1τk ∼ Inverse Wishart|τk|(δτk , λτkI|τk|),
bvw ∼ N(0, c2vw/κvv) for all v ∈ τk and w ∈ Ck−1 ,
(8)
where λτk > 0 and δτk > 0 for all k = 1, . . . , q, and cvw are constants. The prior of each
regression coefficient bvw is dependent on the precision κvv of the variable Yv (vth diagonal
element of K).
In essence, we are able to divide the estimation problem of the mlGGM in (3) into
smaller multivariate regression problems by specifying the priors that are independent
across τ ∈ T in (8). The Wishart distribution is the global conjugate priors for the precision
matrices and, equivalently, the covariance matrix follows the Inverse Wishart distribution.
However, the number of parameters greatly increases as the total number of variables from
multiple layers increases. For estimating the two-layered GGM for the kth component, τk,
we have |τk||Ck−1|+ |τk|(|τk|+1)/2 number of parameters for the directed edges, undirected
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edges, and the variances of the variables in τk. The number of parameters is 3775, even
for |τk| = 50 and |Ck−1| = 50. Moreover, the number of parameters becomes larger when
we handle downstream layers, due to the increasing number of preceding layers. Bhadra
and Mallick (2013) and Consonni et al. (2017) proposed a joint selection of the nonzero
elements of Bτk,Ck−1 and Kτk , where the undirected relations encoded in Kτk correspond
to the limited space of decomposable graphs using the hyper-inverse Wishart prior (Dawid
and Lauritzen, 1993). Moreover, the method selects entire columns of the coefficient matrix
Bτk,Ck−1 , and fails to select single elements of this matrix (i.e., a variable in an upper layer
is either connected to all variables in a lower layer or to none), and the same precision
matrix Kτk informs the selection of the coefficient matrix Bτk,Ck−1 . Assumptions on both
Bτk,Ck−1 and Kτk , while improving computational efficiency due to conjugate formulation
and allowing for the exact calculation of the marginal likelihood of the graph, impose the
artificial restriction on both undirected and directed structures, and may potentially result
in misspecification of the networks structures. In particular, the space of decomposable
graphs corresponding to Kτk is increasingly sparse with the increasing size of τk. For
example, the percentages of graphs that are decomposable decrease as 95%, 80%, 55%,
29% and 12% for |τk| = 4, 5, 6, 7, and 8, respectively (Armstrong, 2005).
4 Bayesian node-wise selection (BANS) framework
To circumvent the above-mentioned challenges, we develop a model selection procedure
that allows for more general graph space than the procedures proposed by Bhadra and
Mallick (2013); Consonni et al. (2017), as well as greater computational efficiency than
the joint model formulation. We propose a Bayesian node-wise selection (BANS) method
to jointly estimate undirected edges and directed edges of mlGGMs, using a node-wise
regression framework. For a node, the Bayesian variable selection approach simultaneously
finds its neighbors and parents, which are connected by undirected and directed edges,
respectively.
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4.1 Working model
For all v ∈ V , Cv and Pv are defined by the set of all other vertices in the same layer as
v, τt(v) \ {v} and all the preceding vertices, Ct(v)−1, respectively. We consider multivariate
regression between τt(v) as responses and Pv as predictors. Note that the sets in {Pv : v ∈ τ}
are all the same, and we consider Pv = Pτ for v ∈ τ . We re-express models (6) and (7) to
node-wise regressions:
Yv = Y
T
Pvbv + v for all v ∈ V,
where  = (1, . . . , p)
T ∼ N(0,K−1) and bv is a |Pv| × 1 vector of {bvu : u ∈ Pv}. For
the well-known conclusion that gives the relation between the concentration matrix of the
multivariate normal distribution and the regression coefficients (Anderson, 1984), we have
the following lemma.
Lemma 1. For all v ∈ V , v = TCvαv + ev, where αv = −KCv ,v/κvv and ev ∼ N(0, 1/κvv)
is independent of V \{v}.
The undirected edges encoded in the zero structures of the precision matrix K can be
found by the zero structures of the regression coefficients obtained from regressing each
residual v to the residuals corresponding to the other vertices in the same layer.
Proposition 1. For all v ∈ V , Yv = Y TPvbv + Y TCvαv − Y TPvBTCv ,Pvαv + ev, where αv =
−KCv ,v/κvv and ev ∼ N(0, 1/κvv) is independent of V \{v}.
The proof of Proposition 1 is provided in Section S2. From Proposition 1, we coherently
convert the estimation problem of mlGGM in (3) to that of node-wise regressions. For a
given node, both undirected edges between vertices in the same layer and directed edges
toward the vertex can be jointly uncovered by model selection for a regression model. Our
working model can be re-expressed as follows: for all v ∈ V ,
Yv =
∑
i∈Pv
bviYi +
∑
j∈Cv
αvjYj +
∑
j∈Cv
αvj
∑
i∈Pv
−bjiYi + ev, (9)
where ev ∼ N(0, 1/κvv). Our model (9) for a vertex v ∈ V involves regression coefficients
for the directed edges from the vertices in the preceding layers (Pv → v), undirected edges
from the vertices in the same layer (Cv − v), and directed edges from the vertices in the
preceding layers to the vertices in the same layer other than v (Pv → Cv).
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A simple illustrative example. Consider the linear model corresponding to the chain graph
with two layers for genes {Y1, Y2} and proteins {Y3, Y4} described with solid lines in Figure 2
(a): Y1 = 1, Y2 = 2, Y3 = b31Y1 + 3, and Y4 = b42Y2 + 4, where 1 and 2 and (3, 4)
are mutually independent, and 3 and 4 (the residuals of proteins after taking out effects
from genes) have bivariate normal distribution with an arbitrary covariance matrix. The
undirected edge between proteins Y3 and Y4 is estimated by the regression coefficients, α43
and α34, from the two regressions for responses Y3 and Y4 in our working model with true
nonzero regression coefficients, as shown in Figure 2 (b). For example, for the protein Y3,
Figure 2: An example of a chain graph with layers {1, 2}, {3, 4}. For example, the first
layer {1, 2} and the second layer {3, 4} represent gene and protein expressions, respectively.
(a) Solid lines represent the data generating structure and dotted lines display how we
parameterize undirected edges in our neighborhood selection framework. (b) Our working
model.
our working model includes effects for the parent gene Y1, the neighbor protein Y4, and the
indirect effect of the neighbor’s parent gene Y2. Therefore, when we select directed and
undirected edges for a biological unit v, the indirect effects of its neighbor’s parents are
adjusted.
The next step is to deduce the prior distribution of {αv|v ∈ V } from the joint prior on
the precision matrix K. The priors in (8) are re-expressed as follows: for all τ ∈ T ,
αvw|κvv ∼ N(0, 1/(λτκvv)) for all v ∈ τ and w ∈ Cv,
κvv ∼ Gamma(δτ + |τ | − 1
2
,
λτ
2
) for all v ∈ τ ,
bvw ∼ N(0, c2vw/κvv) for all v ∈ τ and w ∈ Pv,
(10)
where the Wishart prior on Kτ translates to normal and gamma priors on αv and κvv for
v ∈ τ .
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4.2 Model selection priors
Our goal is to infer the dependence structure of the underlying chain graph of the data Y.
Using our framework, the undirected and directed edges of the chain graph can be selected
using zero restrictions on the regression parameters, B and α. Based on the priors in (10),
model selection is achieved through a mixture prior on the regression coefficients: for all
v ∈ τ , w ∈ Pv, u ∈ Cv, and τ ∈ T ,
Directed edges: bvw|γvw, κvv ∼ γvwN(0, c2vw/κvv) + (1− γvw)δ0,
Undirected edges: αvu|ηvu, κvv ∼ ηvuN (0, 1/ (λτκvv)) + (1− ηvu)δ0,
Variance parameters: κvv ∼ Gamma(δτ + |τ | − 1
2
,
λτ
2
),
(11)
where δ0 is the Dirac delta function and cvw, λτ , and δτ are fixed hyperparameters. We
complete the formulation of our model by specifying the prior on γvw and ηvw:
P (γvw = 1) = pvw and P (ηvw = 1) = qvw,
where pvw and qvw are fixed hyperparameters. The binary indicators, γvw and ηvw, are latent
variables that encode the directed structure between layers and the undirected structure
within a layer. If γvw = 1 , the arrow from w to v (w → v) is included in the graph, and
γvw = 0 otherwise. If ηvw = 1, the undirected edge between v and w (v − w) is present in
the graph.
5 Likelihood and posterior inference
For each vertex, we implement the Bayesian procedure to select the parents from the
preceding layers and neighbors from the same layers as the vertex. Let Y = (y1, . . .yp)
and YA for a set A ⊂ V be a n × p data matrix and n × |A| sub-matrix of Y for which
the columns correspond to the set of vertices A. From Proposition 1, we have the following
node-wise likelihood function:
L =
∏
τ
∏
v∈τ
p(yv |YCv∪Pv ,αv , κvv ,Bτ,Pv )
=
∏
τ
∏
v∈τ
(κvv
2pi
)n/2
exp
{
−κvv
2
(
yv −YPvbv −YCvαv +YPvBTCv,Pvαv
)T (
yv −YPvbv −YCvαv +YPvBTCv,Pvαv
)}
,
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where αv = −KCv ,v/κvv. We construct the likelihood L by pooling conditional densities
within each of the two-layer models. The inference using the likelihood L is not equivalent
to the joint likelihood from our original model in (6) and (7), because the resulting local
distributions are likely to be inconsistent in that there is no joint distribution p(Y τ |Y Pτ )
from each of the local distributions p(Yv|Y Cv∪Pτ ) (Heckerman et al., 2000). The results are
asymmetry of the structure, magnitudes, and signs inferred from {αv : v ∈ V } between α43
and α34 in Figure 2. The neighborhood selection approach (Meinshausen and Bu¨hlmann,
2006) for UGs requires a symmetrization step after estimating the regression coefficients for
all node-wise regressions. Similarly, in our model framework, the set of undirected edges
can be defined by {v−w : ηvw = 1 and ηwv = 1} or {v−w : ηvw = 1 or ηwv = 1}. For more
accurate inference on the graphical structure, instead of using the post-hoc symmetrization,
we implement MCMC sampling (BANS) to estimate the posterior distributions with the
symmetric constraint ηvw = ηwv and showed better accuracy in the structural learning than
post-hoc symmetrization obtained from BANS-parallel (Section S7.5 in the Supplementary
Materials). However, considering the gain in computation efficiency by using the node-
wise parallelizable procedure, BANS-parallel is scalable and useful for high-dimensional
problems (Section S7.5 in the Supplementary Materials).
5.1 MCMC Sampling
Our neighborhood selection approach for the chain graph model enables us to estimate the
chain graph via a vertex-wise variable selection framework. Now we consider estimating
the undirected edges and directed edges toward a vertex v. Since the parameter spaces for
the binary indicators η and γ are enormous, computing the explicit posterior probabilities
for all possible subsets poses computational challenges. Instead, we use a stochastic search
variable selection (SSVS) to generate a Gibbs sequence for each vertex v (George and
McCulloch, 1993). Our sampling scheme consists of two parts for updating undirected edges
and directed edges. The symmetric constraints of the UG structure can be incorporated
when sampling η by assuming ηvw = ηwv for v 6= w. The MCMC algorithm, which is
described in detail in Section S3 can be summarized as follows. For a vertex v ∈ τ ⊆ V at
iteration t:
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1. Undirected edges
1.1 Set y˜v = yv −YPvbv and Xv = YCv −YPvBTCv ,Pv .
1.2 Update {ηk : k ∈ τ} and set ne(t)v = {w ∈ τ : ηvw 6= 0}.
1.3 Update
{
αk : k ∈ {v} ∪ ne(t)v
}
, and
{
κkk : k ∈ {v} ∪ ne(t)v
}
.
2. Directed edges
2.1 Set y˜v = yv−YCvαv and Xτ =
(
YPv −αvu1YPv −αvu2YPv . . .
)
, where u1, u2, . . .
are vertices in ne
(t)
v .
2.2 Update {γv : v ∈ τ}, Bτ,Pv , and κvv.
Sampling parameters that correspond to undirected edges are not independent among the
vertices in the same layer, due to the imposed symmetric constraints. Thus, our MCMC
sampling is performed for each layer. Within an MCMC sampling, steps 1 and 2 are
repeated for all vertices in a layer. The mlGGM estimation using this MCMC sampling
method is called BANS. We also implemented node-wise sampling scheme, called BANS-
parallel in Section S6.
5.2 Graphical structure estimation
The posterior samples of the model parameters for undirected and directed edges obtained
from our MCMC methods are used to perform Bayesian inference. The MCMC samples
explore the distribution of possible graphs, with each graph leading to a different topology
based on the model parameters. The maximum a posteriori (MAP) estimate represents
the mode of the posterior distribution of possible graphs. This approach is not feasible,
however, since the space of possible graphs is large and the most likely graph may still
appear only in a very small proportion of MCMC samples. An alternative and practical
solution is to select the edges marginally by using all of the MCMC samples and averaging
the presence/absence of each edge over the MCMC samples (Hoeting et al., 1999).
We propose a false discovery rate (FDR)-based determination of significant networks.
Our MCMC methods are applied to each of the layers as responses, with all the preced-
ing layers as predictors. For each layer, suppose we have M posterior samples of the
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corresponding parameter set. From M MCMC iterations for all layers, we estimate the
posterior marginal probability of edge inclusion for each edge gvw as the proportion of
MCMC iterations after the burn-in in which the edge v − w for t(v) = t(w) or w → v
for t(w) < t(v) was selected in the graph. The values 1 − gvw can be considered as
Bayesian q-values, or estimates of the local FDR (Storey and Tibshirani, 2003; Newton
et al., 2004), if the vwth edge is called a discovery. Given a desired FDR level α ∈ (0, 1),
we call the set of edges Xφα = {(v, w) : gvw > φα} discoveries. The significance thresh-
old φα can be determined based on the approach of Baladandayuthapani et al. (2014).
We first sort all {gvw} in descending order to yield {g(t)}. Then we set φα = g(ξ), where
ξ = max{k|k−1∑kj=1(1 − g(j)) < α}. We expect that only 100α% of the discovered edges
Xφα are false positives. An alternative approach is to select the set of edges that appear
with marginal posterior probability of inclusion greater than φα = 0.5 (Barbieri and Berger,
2004). This rule results in an expected FDR for φα
FDR =
∑
(v,w) (1− gvw) I(gvw > φα)∑
(v,w) I(gvw > φα)
,
where I is the indicator function.
6 Simulations
The aim of our simulation study is to compare BANS with other joint estimation ap-
proaches under various simulation settings that generate high- and low-dimensional data
under the mlGGM in (3) (Section 6.2.1). We also numerically evaluate the sign consistency
of the estimated partial correlations for undirected edges within layers and the estimated
coefficients bvw for directed edges between layers using our structured sampling approach
(Section 6.2.2). We perform sensitivity analysis of our algorithm to priors (Section S4, Sup-
plementary Materials) and check the convergence (Section S5, Supplementary Materials).
6.1 Data generation with random chain graphs
To generate random chain graphs, we assume that the UGs within layers follow the Erdo¨s
and Re´nyi (ER) model (Erdo˝s and Re´nyi, 1960). A graph that follows the ER model is
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constructed by randomly connecting the vertices. We assume that each undirected edge
within a layer is included in the chain graph with probability pE independent from all
other edges. We also assume that each directed edge between two consecutive layers is
independently linked with probability pE/2. Thus, the vertex i in the graph is almost
surely connected to (|τt(i)| − 1)pE undirected edges and |τt(i)−1 − 1|pE/2 directed edges.
We generate an adjacency matrix A = (Aij)p×p that represents a random chain graph on
V = {1, . . . , p} with Aij = Aji = 1 for i − j, and Aij = 1 and Aji = 0 for i → j. We
use the random chain graph generation procedure as follows: (1) assign p vertices to the
dependence chain T = {τk|k = 1, . . . , q} so that the sizes of the layers are mostly the
same; (2) set independent realizations of Bernoulli(pE) in the lower triangular elements of
the sub-matrix corresponding to each layer, then symmetrize it; and (3) set independent
realizations of Bernoulli(pE/2) in the off-block diagonal elements between two consecutive
layers. Given a randomly generated chain graph G with the dependence chain T , the
observed data are simulated by the mlGGM in equation (3), after setting the intensities of
the nonzero elements of B andK. The nonzero elements of B andK are randomly sampled
from (−1.5,−0.5) ∪ (0.5, 1.5). To guarantee the positive definiteness of K, their diagonal
elements are filled by column-wise sums of absolute values, plus a small constant. Then
we draw a random sample Y of size n from the distribution N(0,Ω−1) with Ω in equation
(4). In the additional simulation setting that emulates the DNA Damage response network
estimated for 309 TCGA lung squamous cell carcinoma (LUSC) samples (Section S7.1), we
used the parameter estimates Bˆ and Kˆ obtained from the real data application to generate
simulation datasets.
6.2 Performance evaluation
6.2.1 Graphical structure estimation
We compare the performance of our BANS method against those of multivariate regression-
based methods in learning the topologies of chain graphs under various simulation settings
of mlGGMs according to the simulation parameters, the number of variables (p), sample
size (n), number of layers (q), and degree of sparsity (pE). We consider the following
multivariate regression-based methods for two-layer models: multivariate regression with
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covariance estimation (MRCE) (Rothman et al., 2010), and covariate-adjusted precision
matrix estimation (CAPME) (Cai et al., 2012), which are available in R packages MRCE and
capme, respectively. We apply glasso (Friedman et al., 2008) for MRCE and CLIME (Cai
et al., 2011) for CAPME to estimate the UG for the first layer, as MRCE and CAPME are
not applicable to UGs.
We investigate the performance of our method under different simulation settings by
varying (p, n, q, pE). Different measures of structural difference can be used to assess the
performance of our method. We define TP, TN, FP, and FN as the total number of true
positive, true negative, false positive, and false negative edges, respectively. For goodness
of estimation, we use sensitivity, specificity, and Matthew’s correlation coefficient (MCC):
Specificity =
TN
TN + FP
, Sensitivity =
TP
TP + FN
, and
MCC =
(TP× TN)− (FP× FN)
{(TP + FP)(TP+FN)(TN + FP)(TN + FN)}1/2 .
MCC ranges from -1 (total disagreement) to 1 (perfect classification), with a larger value
corresponding to a better fit.
Table 1: Simulation results: model selection performances as measured by sensitivity,
specificity, Matthew’s correlation coefficient (MCC), the number of edges detected, partial
area under the curve (pAUC) at specificity=0.8 and area under the curve (AUC), for four
different simulation scenarios, based on 50 replications. Numbers in parentheses are the
simulation standard errors.
Setting Method Sensitivity Specificity MCC Number pAUC(0.8)∗ AUC
(p, n, q, pE) of discoveries
(20,200,6,0.3) BANS 0.99 (0.042) 0.99 (0.005) 0.9 (0.041) 14.3 (0.974) 1 (0.015) 1 (0.003)
# true edges= 12 MRCE 0.99 (0.039) 0.81 (0.046) 0.46 (0.062) 45.64 (8.312) 0.79 (0.048) 0.96 (0.015)
CAPME 1 (0.016) 0.74 (0.056) 0.39 (0.049) 58.84 (9.960) 0.74 (0.055) 0.95 (0.009)
(100,200,6,0.03) BANS 0.94 (0.034) 1 (0.001) 0.87 (0.034) 49.62 (1.947) 1 (0.001) 1 (0)
# true edges= 43 MRCE 1 (0.008) 0.9 (0.021) 0.27 (0.029) 529.08 (100.605) 0.81 (0.015) 0.96 (0.003)
CAPME 1 (0.005) 0.79 (0.028) 0.18 (0.014) 1087.76 (137.793) 0.85 (0.006) 0.97 (0.002)
(100,200,10,0.03) BANS 0.97 (0.021) 1 (0.001) 0.83 (0.031) 34.66 (1.825) 1 (0.001) 1 (0)
# true edges= 25 MRCE 1 (0.008) 0.93 (0.013) 0.25 (0.025) 367.02 (64.609) 0.86 (0.008) 0.97 (0.002)
CAPME 1 (0.008) 0.85 (0.021) 0.17 (0.014) 776.6 (105.138) 0.88 (0.011) 0.98 (0.002)
(200,100,10,0.03) BANS 0.74 (0.024) 1 (0.002) 0.83 (0.015) 91 (3.536) 0.99 (0.002) 1 (0)
# true edges=116 MRCE 0.47 (0.050) 0.98 (0.002) 0.22 (0.017) 469.04 (40.141) 0.87 (0.009) 0.93 (0.013)
CAPME 0.48 (0.029) 0.94 (0.009) 0.13 (0.009) 1327.98 (174.406) 0.79 (0.007) 0.96 (0.004)
∗ scaled to be located between 0 and 1.
18
To evaluate the sensitivity, specificity, MCC, and number of discoveries, we deter-
mine the tuning parameters of glasso, MRCE, CLIME and CAPME using five-fold cross-
validation, and control the FDR at 0.1 for BANS. To further compare the performance on
graph structure recovery, we obtain the receiver operating characteristic (ROC) curve and
the MCC curve as the function of the number of discoveries for each simulation dataset by
varying the tuning parameters for MRCE and CAPME, as well as the cutoff for the poste-
rior marginal probability of edge inclusion for BANS. The sensitivity, specificity, MCC, and
number of discoveries for the selected tuning parameters, and pAUC and AUC obtained
from the ROC curves, are shown in Table 1. In terms of graph structure recovery, our
method yields better performance for all settings. The number of discoveries is very close
to the number of edges in the true graph, while other methods tend to provide a much
greater number of edges. The small standard errors for the number of discoveries suggest
that our procedure is stable across simulation replicates. Figure 3 and Figure S10-S12
display the ROC curves and MCC curves averaged over 50 replications, which demonstrate
that our method performs better than MRCE and CAPME. Our method shows better
ROC curves and MCC curves for all four simulation settings across different tuning param-
eters. In the high-dimensional case, when p = 200 and n = 100 (Figure 3), the sensitivities
of MRCE and CAPME are flattened for some intervals of 1-specificity, and MRCE shows
unstable variable selection performance, because the curves show a decreasing pattern as
the tuning parameters decrease. The Section S7 includes other extensive simulation
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Figure 3: ROC curves and MCC curves for graph structure learning for (p, n, q, pE) =
(200,100,10,0.03).
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studies. We evaluated the performance of BANS in simulation settings where data were
generated from non-Gaussian, and the graphical structures were the same as the estimated
DNA damage response network for 309 TCGA lung squamous cell carcinoma. We per-
formed comparisons to (1) BANS-parallel (Section S6), (2) XMRF (Wan et al., 2016), that
fits UGs to mixed data types, (3) Neighborhood selection of UGs using Horseshoe prior
(Carvalho et al., 2010) and (4) objective Bayes fractional Bayes factor (OBFBF) (Con-
sonni et al., 2017) using model averaging. Given the simulation settings where the data
are generated from Poisson distribution, BANS showed better performance than XMRF
(Section S7.2). For the evaluation of our prior choice, the point mass prior in equation
(11) showed superior performance than Horseshoe prior and OBFBF in estimating UGs
(Section S7.3 and Section S7.4). While BANS-parallel without symmetric constraint in
the MCMC sampling showed smaller AUC and MCC values than BANS, it still performed
better than other methods such as MRCE and CAPME (Figure S8). Considering the gain
in computational efficiency (Section S7.5), BANS-parallel is potentially useful alternative
in high-dimensional setting.
6.2.2 Posterior inference on the signs
The main focus of this section is to make inference on the signs of the edges, conditioned
on the estimated undirected and directed structures using our node-wise regression ap-
proach. We define the sign for an undirected edge as the sign for its corresponding partial
correlation. The partial correlation for an edge v − w is −κvw/√κvvκww, for which the
sign is the same as that of the regression coefficient αvw or αwv. The sign for a directed
edge is straightforward, sign(bvw) for w → v. Thus, the signs of all estimated edges are
obtained by structured estimation of the nonzero elements in B and K. The structured
MCMC sampling scheme can be followed by the same procedure described in Section 5.1
and Section S3, given η and γ. Then the posterior probabilities for negative or positive
signs can be obtained for each edge.
We investigate the performance of the inference on the sign using a simulation study.
We declare that an undirected edge v − w is positive, if P (αvw > 0|data) > ξ, or negative
otherwise; and a directe edge w → v is positive, if P (bvw > 0|data) > ξ, or negative
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Figure 4: ROC curves for posterior inference on predicting positive signs from the struc-
tured estimation. The AUCs were 0.99 for all the scenarios.
otherwise. Figure 4 shows ROC curves for predicting positive signs from the structured
estimation, which was averaged over 50 replications. With AUCs 0.99 for all the four
settings, we can conclude that signs are accurately estimated from our structured estimation
given η and γ, using our node-wise regression model.
6.2.3 Sensitivity and Convergence
We perform sensitivity analysis of our algorithm to priors (Section S4) and check the con-
vergence (Section S5). In assessing the prior sensitivity of the model, we observe that the
choice of λτ and δτ while setting c
2
vw = 1/λτ in equation (11), which are the shape and scale
parameters of the prior on the precision (inverse variance), κvv. Moreover, those hyperpa-
rameters contribute to the variance of the non-zero regression coefficients for undirected
and directed edges. The average PPIs for non-zero edges was consistently higher (around
0.9) than those for zero edges (around 0.1) in the range from 1 to 10 of λτ and δτ (Figure
S2). For a convergence check, we observed that the trace plots from three independent
chains showed that the number of edges included in the graphs had good mixing around a
stable model size, and no strong trends (Figure S3).
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7 Pan-Cancer Network Anaysis of Multi-platform Omic
Data
Biological motivation Crosstalk within signaling pathways and their perturbation by
oncogenes limit single gene-based approaches to understanding cancer biology. Approaches
have been developed for discovering mutations that perturb signaling networks (so-called
network-attacking mutations) to understand how individual genomic variants initiate net-
work perturbation (Creixell et al., 2012, 2015). Although genomic variants are critical
to understanding functional cancer networks, it is well-established that complex molecular
networks and systems are formed by a large number of interactions of genes and their prod-
ucts, which operate in response to different cellular conditions (Bandyopadhyay et al., 2010;
Luscombe et al., 2004). Therefore, systematic approaches to unravelling cancer-specific
rewiring of molecular networks are key to the successful identification of network-based
drug targets for cancer treatment, in the paradigm of network medicine that acknowledges
the application of network topology and dynamics towards identification of therapeutic
targets (Califano, 2011; Baraba´si et al., 2011).
TCGA PanCancer Atlas initiative (Weinstein et al., 2013) built a uniformly-processed
dataset and a unified data analysis pipeline to develop an integrated picture of commonali-
ties and differences across tumor types. Recent studies (Hoadley et al., 2018; Sanchez-Vega
et al., 2018) reclassified human tumor types based on molecular similarity and investi-
gated co-occurence of alterations in tumor signaling pathways, which differentiate between
individual tumors and tumor types using TCGA pan-cancer data. (Akbani et al., 2014) in-
vestigated correlations between protein and other data types, such as mRNA, copy number,
and mutation data across cancer. (Gong et al., 2017) performed expression quantitative
trait locus (eQTL) analysis that focuses on the links between genotypes and gene expres-
sion for pan-cancer TCGA data. These methods only consider links between two platforms;
they do not incorporate within platform dependencies. Using our BANS method, graph-
based multi-level integration approach, our goal is to understand unified interplay within
and between genomic, epigenomic, transcriptomic, and proteomic platforms to elucidate
the commonalities and differences in systems across cancer types.
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Data structures We applied our method to multi-omic datasets from the 7 TCGA tu-
mor types, lung adenocarcinoma (LUAD, n=356), lung squamous cell carcinoma (LUSC,
n=309), colon adenocarcinoma (COAD, n=338), rectum adenocarcinoma (READ, n=121),
uterine corpus endometrial carcinoma (UCEC, n=393), ovarian serous cystadenocarcinoma
(OV, n=227), and skin cutaneous melanoma (SKCM, n=333). For each of the tumor types,
we included multi-platform data, DNA methylation, copy number alteration, mRNA ex-
pression data, and reverse phase protein array (RPPA)-based proteomic data. Genomic
features from each data platform constitute a layer; the ordering of the layers follows bi-
ological justifications, because of the natural interplay among diverse genomic features:
gene encoded by DNA is transcribed to mRNA, mRNA is translated to protein, and DNA
methylation helps to regulate transcription (Morris and Baladandayuthapani, 2017) (Fig-
ure 5).
Figure 5: Inter-relationships between multi-platform data, copy number aberration (CNA),
DNA methylation, nRNA expression, and protein.
Based on the principle that within-platform interactions arise from pathway-based de-
pendencies that are altered across different tumor types, we selected 10 key signaling path-
ways, based on emerging literature on RPPA-based proteomic profiling of various tumor
types (Akbani et al., 2014; Cherniack et al., 2017; Li et al., 2017). The pathways and
the gene membership for each pathway are listed in Table S1. We focus on building inte-
grative networks for all combinations of the 10 pathways and the 7 cancer types. Using
TCGA-Assembler (Zhu et al., 2014), we downloaded CNA, DNA methylation, mRNA ex-
pression, and protein expression data, then matched the samples across platforms. We
applied BANS separately to each type of cancer and pathway combination (10×7=70 anal-
yses). The MCMC sampler was run for 10,000 iterations of burn-in, followed by 20,000
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iterations as the basis for inference. For each analysis, we estimated the graph structure at
FDR 0.1 and obtained the signs of each nonzero coefficient using the cutoff ξ = 0.5 for the
posterior probability of the signs from the structured estimation. Figures S13-S22 display
the estimated networks for all pathways and cancer types.
7.1 Global commonalities and differences in mlGGMs
We first investigated the number of edges that are shared, differentiating across different
cancer types for each of the possible edges at the platform level. For each combination of
the cancer types and pathways, the mlGGM contains 4 layers at CNA, DNA methylation,
mRNA expression, and protein expression, and allows 9 different types of dependencies,
represented by the 4 types of undirected edges (i.e., CNA−CNA, methylation−methylation,
mRNA−mRNA, and protein−protein) and the 5 types of directed edges (i.e., CNA→mRNA,
CNA→protein, methylation→ mRNA, methylation→protein, and mRNA→protein) (Fig-
ure 5). Across all pathways, our BANS method detected 433 (UCEC), 350 (SKCM),
328 (OV), 240 (READ), 391 (COAD), 394 (LUAD), and 361 (LUSC) directed/undirected
edges in the estimated mlGGMs. Across all 10 pathways, we decomposed the edges by
the aforementioned 9 types of dependences within and between the four layers, as well as
the numbers of intersecting edges across the 7 cancer types are depicted using UpSet plots
(shown in Figure 6). UpSet plot is an effective visualization of intersections for more than
three sets, and a more-scalable approach than Euler diagrams (Lex and Gehlenborg, 2014).
For each of the 9 possible relations within and between layers, the UpSet plot contains
column and row bar plots. The column bar plot encodes all edge set intersections in the
columns of a matrix using a binary pattern, and renders bars above the matrix columns to
represent the number of exclusively intersecting edges that are shared by the correspond-
ing cancer types to the column, but not of the others. The row bar plot displays the total
number of edges for each cancer type.
Between platform regulatory relations: Transcriptional and translational effects represented
by directed edges CNA→mRNA (Figure 6-b) and mRNA→ Protein (Figure 6-h) tend to
be shared across cancer types, which is along expected lines of the basic biological mech-
anisms. For example, in Figure 6-b, 36 edges were shared by all 7 cancer types, and few
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unique edges to a cancer type were found. We found few regulatory edges from CNA to
proteins, and from methylation to mRNA and Protein across cancer types (Figure 6-c,e,f).
For example, for Methylation→ mRNA in Figure 6-e, we found 7 edges unique to OV and
COAD.
Within platform conditional dependencies: The undirected edges represent dependencies
within platform after taking out the regulatory effects from upstream platforms. The
dependence structures within platforms tend to be unique to cancer type. For CNA (Fig-
ure 6-a), UCEC, COAD, LUSC, and LUAD had 23, 15, 11, and 7 edges that are not shared
by any other cancer types, while 6 edges were shared across all cancer types. For Methy-
lation (Figure 6-d), OV included 14 unique edges among 48 edges in total. For mRNA
(Figure 6-g), SKCM had 13 of 45 edges that were unique. For protein (Figure 6-i), UCEC
had the largest protein network, with 62 protein-protein interactions, 13 of which were
unique to the cancer, while the same number of the edges were shared across all cancer
types.
7.2 Pan-cancer network signaling
We investigate the extent of cross-signaling within- and between- layers for each pathway
across tumor types. For a given network, we define the ratio of the observed number of
edges to the total number of possible edges as connectivity score (CS): high (low) CS value
indicates high (low) cross-signaling of the network. We also compute standard deviation of
CS values across cancer types to represent that the levels of connectivity of the network are
different across tumor types: the genes in the network are highly connected (high signaling)
in some cancers, but have few connection (low signaling) in other cancers. Figure 7 displays
the CS values and the variability are displayed: CS ranged from 0 to 0.5, and the variability
ranged from 0 to 0.17. The overall pattern of the heat map suggests that the within-layer
sub-networks had a higher level of signaling than between-layer sub-networks. The core
reactive pathway showed a high level of network signaling within platforms, and the highest
level of protein-protein signaling across tumor types, which suggests that our estimation
aligns well with the a priori functional characteristics of this pathway, which was defined
on the basis of all tumor types (Akbani et al., 2014). The CS was markedly different in
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methylation-methylation networks for most of the pathways, compared to other types of
sub-networks: the apoptosis pathway for LUAD and COAD, cell cycle pathway for OV,
EMT pathway for UCEC, TSC/mTOR pathway for LUAD, breast reactive pathway for
UCEC, and core reactive pathway for READ, UCEC, and SKCM showed the high level of
signaling for methylation-methylation. The transcriptional and translational effects that
are represented by CNA→mRNA and mRNA→protein sub-networks showed the high-level
of signaling across pathways and cancer types, compared to other between-layer networks,
again following along expected lines of the biological hierarchy.
7.3 p53 Integrative Networks
In this section we focus on a gene/protein of particular interest (i.e., p53) across all tumor
types. p53 is the most frequently mutated gene in human tumors, and has a central role
as a tumor suppressor and novel therapeutic target (Bouchet et al., 2006; Farnebo et al.,
2010; Levine, 2019). The transcription factor p53 is activated downstream of the DNA
damage response (DDR) in reaction to cell stress, and mediates distinct outcomes of DDR
signaling (Reinhardt and Schumacher, 2012). The TP53 gene encodes the p53 protein that
targets a large set of genes associated to apoptosis and cell cycle pathways (Bouchet et al.,
2006; Reinhardt and Schumacher, 2012). Due to the high level of inter-connectivity of the
DDR with other signaling networks, predicting the efficacy of treatment and designing an
optimal combination therapy to target multiple genes will require a detailed understanding
of the tumor-specific signals of other molecules.
Let gij be the estimated posterior marginal probability of the edge (i − j or i → j)
inclusion. We consider the estimated mlGGMs are weighted graphs, whose edges have been
assigned the given posterior inclusion probabilities, and the degree of the nodes across all
layers are defined as the summation of the weights for the edges that are connected to the
node (Barrat et al., 2007):
Wi =
p∑
j=1
I(i→ j or i← j or i− j)gij,∀i ∈ V.
The degree of the nodes in a weighted mlGGM measures the strength of nodes in terms of
the total weight of their directed and undirected connections. With the goal of studying
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the underlying mechanism of p53 protein, we focused on the sub-networks of the estimated
mlGGMs, which include the nodes connected to the p53 protein by any lengths of paths
including both undirected and directed edges. Figure 8 displays the p53 integrative net-
works, where the edges are colored and weighted by the signs and the posteriors, gij, and
the sizes of nodes are weighted by their degrees, Wi.
7.3.1 Translational findings
Our results confirm that the transcriptional effect from TP53 at CNA to TP53 gene ex-
pression, and translational effects from TP53 gene expression to the p53 protein across 6
tumor types (all except for SKCM), all with positive regulations. In contrast, the SKCM
network included no upstream regulatory effects (from DNA and RNA) and only included
protein-protein interactions. UCEC and SKCM shared the same protein-protein interac-
tions between p53 protein expression and T68 phosphorylated CHK2 (CHK2PT68): CHK2
is a protein kinase that is activated in response to DNA damage and directly phosphory-
lated p53 on serine 20, which provides a mechanism for increased stability of p53 (Hirao
et al., 2000) and has been suggested as an anticancer therapy target given its role as
a tumor suppressor (Zannini et al., 2014). These findings prioritize UCEC and SKCM
as potential cancer types for CHK2 targeting. We also found epigenetic effects in the p53
sub-networks: only UCEC had a positive regulatory effect from BRCA2 DNA methylation,
which was correlated with CHEK1 DNA methylation. The physical and functional inter-
actions between BRCA2 and TP53 have been reported and hypermethylation of the CpG
island in the promotors of BRCA2 gene involve their inactivation and therefore a higher
risk of developing a tumor including uterine cancer (Rajagopalan et al., 2010; Bosviel et al.,
2012). Epigenetic drugs have been developed and the anticancer effects are often tested us-
ing genome-editing technologies such as CRISPR-Cas9 systems, called Epigenome editing,
which provides advantages over direct gene knockout based on RNA interference (Kun-
gulovski and Jeltsch, 2016). Moreover, successes of epigenetic drugs have been reported
by the important roles in synergy with other anticancer therapies or in reversing acquired
therapy resistance (Morel et al., 2019). Our findings through this deeper investigation of
underlying biological mechanisms of p53 networks across multiple molecular levels and can-
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cer types have the potential to facilitate the development of novel therapeutic strategies,
specifically gene-drug interactions for single and combination agents.
8 Discussion
We propose a unified Bayesian framework to model the layered architecture of networks
from multiple omic data. We employ a multi-layered Gaussian graphical model (mlGGM)
to investigate the conditional dependencies among the variables from multiple layers, while
accounting for the order defined by biological hierarchies. The mlGGM is built upon a
multivariate regression framework with mean and residual precision parameters, for which
zero structures represent undirected and directed edges in the chain graph. Our fully proba-
bilistic formulation coherently converts the complex mlGGM into more tractable, node-wise
multiple regression models, wherein the zero structures of the regression coefficients encom-
pass both the undirected and directed edges. Our edge-specific variable selection priors on
node-wise regression models allow for flexible modeling of any type of graph, without re-
striction to decomposable graphs, as well as the incorporation of relevant prior knowledge,
while maintaining computational efficiency. We applied our Bayesian node-wise selection
(BANS) method to Pan-cancer integrative network analysis and found structural common-
alities and differences across cancer types. We also identified underlying mechanisms of the
p53 protein, which is a novel drug target for cancer treatment.
For identifiability, the main assumption in this article is that the layers have natural
ordering. Ma et al. (2008) and Ha et al. (2015) proposed methods to estimate a Markov
equivalence class of a chain graph and a DAG (as a special case of the chain graph model)
by recovering skeletons on its subgraphs with no ordering information. In the absence of
natural ordering, a chain graph is not identifiable and only its Markov equivalence class
can be identified. In many applications, the vertices are naturally partitioned into multiple
ordered layers, along with time points or the intrinsic biological mechanisms.
For chain graph models, there are two main types of conditional independencies implied
by the LWF Markov property and the alternative Markov property (AMP). Through zero
structures of the mean parameter B and the residual precision matrix K in the mlGGM
in (3), we describe the AMP on chain graph models. For the LWF Markov property in
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high-dimensional Gaussian settings, Sohn and Kim (2012); McCarter and Kim (2014) made
a convex formulation by using a conditional joint distribution given the predictors. The
AMP Markov property is coherent, however, with data generation (as described in Section
S1) by the direct link between the zero structure of the parameters in the multivariate
linear regressions, and the presence/absence of edges in the graph.
For the resulting asymmetry of the structure, we impose the constraint on K during
MCMC. Although most graphical model selection approaches based on node-wise regres-
sions focus on estimating the structure, we showed the numerical performance of estimating
signs of the directed edges and undirected edges, based on the structured estimation from
the conditional posterior P (α,κ,B|Y,η,γ), where η and γ are subjected to the structure
G.
Our node-wise regression-based formulation, BANS to jointly estimate the undirected
and directed edges to a node provides a flexible modeling framework. In particular, the
proposed approach can be extended to allow nonlinear regulatory relations between layers,
instead of the linearity assumption on the parameter B, and to infer multiple mlGGMs
where some of the graphs may be unrelated, while others share common edges. BANS R
codes implementing our method are available on https://github.com/***/BANS.
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Figure 6: UpSet plots showing relationships of mlGGMs across all 10 pathways between 7
cancer types. Each column-wise bar corresponds to the number of exclusively intersecting
edges that are shared by the cancer types represented by the dark circles, but not of the
others, and each row-wise bar displays the total number of edges for the corresponding
cancer type.
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Figure 7: Heatmap depicting connectivity score (CS) of the within- and between-layer sub-
networks of the estimated mlGGMs across the 7 cancer types and 10 pathways. The scores
are indicated on a low-to-hig scale (grey-red-black). The standard dev a i ns of the CS
values across cancer types are displa ed in the barplots.
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Figure 8: Integrative sub-networks for the p53 protein (red circle), inferred from BANS
for LUAD, LUSC, COAD, READ, UCEC, OV, and SKCM. Each connected component
includes all nodes that are connected to the p53 protein by any lengths of paths, including
both undirected and directed edges for each cancer. The colors of edges indicate the inferred
signs of the edges: negative (red) and positive (blue). The sizes of nodes and the widths of
edges are weighted by their degrees and posterior edge inclusion probabilities, respectively.
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